Two-hour glucose predicts the development of hypertension over 5 years: The AusDiab study

Journal of Human Hypertension

Volumn 22, Issue 3, 2008, Pages 168-176

  Boyko, E J ^a,b,c   Barr, E L M ^a   Zimmet, P Z ^a   Shaw, J E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; AUSTRALIA; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; EDUCATIONAL STATUS; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AUSTRALIA; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS;

EID: 39449088452     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002316     Document Type: Article

References (43)

1. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003; 26: 2910-2914.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16 434-444.
3. Glucose Tolerance and Cardiovascular Mortality. Comparison of fasting and 2-h diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-240.
5. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 1050-1054.
6. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The stop-niddm trial. JAMA 2003; 290: 486-494.
7. Fagot-Campagna A, Balkau B, Simon D, Ducimetiere P, Eschwege E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997; 26: 542-550.
8. Haffner SM, Valdez R, Morales PA, Mitchell BD, Hazuda HP, Stern MP. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care 1992; 15: 1277-1284.
9. Suematsu C, Hayashi T, Fujii S, Endo G, Tsumura K, Okada K et al. Impaired fasting glucose and the risk of hypertension in Japanese men between the 1980s and the 1990s. The Osaka health survey. Diabetes Care 1999; 22: 228-232.
10. Vaccaro O, Imperatore G, Iovino V, Iovine C, Rivellese AA, Riccardi G. Does impaired glucose tolerance predict hypertension? A prospective analysis. Diabetologia 1996; 39: 70-76.
11. Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK et al. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: The Strong Heart Study. Hypertension 2006; 47: 403-409.
12. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140 992-1000.
13. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005; 95(Suppl 1): S144-S150.
14. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J et al Overweight and obesity in Australia: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 178: 427-432.
15. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates. Diabetes Res Clin Pract 2002; 57 119-129.
16. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle study. Diabetes Care 2002; 25: 829-834.
17. Australian Institute of Health and Welfare (AIHW). The Active Australia Survey: A Guide and Manual for Implementation, Analysis, and Reporting. Australian Institute of Health and Welfare: Canberra, 2003.
18. Ireland P, Jolley D, Giles G, O'Dea K, Powles J, Rutishauser I et al Development of the Melbourne ffq: A food frequency questionnaire for use in an Australian Prospective Study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994; 3: 19-31.
19. Lewis J, Milligan G, Hunt A. Nuttab95 Nutrient Data Table for use in Australia. Australian Government Publishing Service: Canberra, Australia, 1995.
20. Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA et al. Associations of tv viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia 2005; 48 2254-2261.
21. Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, McNeil JJ et al. Untreated hypertension among Australian adults: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 179: 135-139.
22. World Health Organization. Definitions, Diagnosis, and Classifications of Diabetes Mellitus and Its Complications. World Health Organization: Geneva, 1999.
23. Wallace TM, Levy JC, Matthews DR. Use and abuse of home modeling. Diabetes Care 2004; 27: 1487-1495.
24. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW et al Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003; 254: 555-563.
25. Long J, Freese J. Regression Models for Categorical Dependent Variables Using Stata. Stata Corporation: College Station, 2001.
26. Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323: 1123-1124.
27. Cleveland WS. Robust locally weighted regression and smoothing analysis. J Am Stat Assoc 1979; 74: 829-836.
28. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 2007; 165: 710-718.
29. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
30. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005; 28: 888-894.
31. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: An update. Ann Intern Med 2002; 137: 25-33.
32. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29: 1909-1914.
33. Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D et al. Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update. Nutr Metab Cardiovasc Dis 2006; 16: 453-456.
34. Ceriello, A, Quatraro A, Giugliano D. Diabetes mellitus and hypertension: The possible role of hyperglycaemia through oxidative stress. Diabetologia 1993; 36: 265-266.
35. Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins c and e. J Am Coll Cardiol 2000; 36: 2185-2191.
36. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.
37. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
38. Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR et al. Postprandial glucose regulation: New data and new implications. Clin Ther 2005; 27(Suppl 2): S42-S56.
39. Svatikova A, Wolk R, Gami AS, Pohanka M, Somers VK. Interactions between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep 2005; 5: 53-58.
40. Kristman V, Manno M, Cote P. Loss to follow-up in cohort studies: How much is too much? Eur J Epidemiol 2004; 19: 751-760.
41. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998; 35(Part 1): 62-67.
42. Armstrong BG. Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med 1998; 55: 651-656.
43. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 1003-1010.